Connection

Stephen Kent to Piperazines

Back to Details
This is a "connection" page, showing publications Stephen Kent has written about Piperazines.
Stephen Kent
Connection Strength
0.035
Piperazines
  1. The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial. Lancet HIV. 2018 05; 5(5):e221-e230.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.